The performance of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key markets has introduced significant uncertainty . Investors are now facing the effect of generic competition , dimin